actilyse cathflo
boehringer ingelheim (nz) limited - alteplase 2mg (per vial) - powder for injection - 2 mg - active: alteplase 2mg (per vial) excipient: arginine phosphoric acid polysorbate 80 - actilyse cathflo is indicated for thrombolytic treatment of occluded central venous access devices including those used for haemodialysis. the 2 mg strength of alteplase (actilyse cathflo) is the only recommended presentation for use in this indication.
actilyse 50 mg/50 ml inj./inf. sol. (pwdr. + solv.) i.v. vial
boehringer ingelheim scomm-commv - alteplase 50 mg - powder and solvent for solution for injection/infusion - 50 mg/50 ml - alteplase 50 mg - alteplase
actilyse 20 mg/20 ml inj./inf. sol. (pwdr. + solv.) i.v. vial
boehringer ingelheim scomm-commv - alteplase 20 mg - powder and solvent for solution for injection/infusion - 20 mg/20 ml - alteplase 20 mg - alteplase
dindevan 10mg tablets; phenindione 10mg tablets
mercury pharma group limited no. 1 croydon, 12-16 addiscombe road, croydon cr0 0xt, united kingdom - phenindione - tablet - phenindione 10 mg - antithrombotic agents
actilyse powder lyophilized for solution for infusion with solvent
boehringer ingelheim pharma gmbh & co. kg - alteplase - powder lyophilized for solution for infusion with solvent - 50mg
actilyse
boehringer ingelheim pty ltd - alteplase -
activase rt-pa inj powder for solution
hoffmann-la roche limited - alteplase - powder for solution - 29m - alteplase 29m - thrombolytic agents
lysatec rt - pa powder for solution
genentech inc - alteplase; water - powder for solution - 50mg; 50ml - alteplase 50mg; water 50ml - thrombolytic agents
actilyse cathflo 2 mg inj./inf. sol. (pwdr.) i.v. vial
boehringer ingelheim scomm-commv - alteplase 2 mg - powder for solution for injection/infusion - 2 mg - alteplase 2 mg - fibrinolysin
actilyse 50 mg/vial polvo liofilizado + solvente para solución inyectable i.v.
boehringer ingelheim pharma gmbh & co. kg - alteplase - alteplase....50.0 mg / agua esterilizada para inyecciÓn....50.0 ml